Affine Formulations
Ticker >

Affine Formulations share price

Affine Formulations Ltd.

SECTOR: Pharmaceuticals & Drugs  1598   1   0

The company is currently not listed and is under IPO, so all the data might not be available.
*It is just an analytical rating of the company and not an investment advice.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

Ratios

Sales Growth

1 Year3.49%
3 Year-7.07%
5 YearNA

Profit Growth

1 Year-8.85%
3 Year12.33%
5 YearNA

ROE%

1 Year11.21%
3 Year10.18%
5 Year10.86%

ROCE %

1 Year13.29%
3 Year12.44%
5 Year12.46%

Debt/Equity

1.08539027469418

Price to Cash Flow

0

Interest Cover Ratio

2.16442024457735

CFO/PAT (5 Yr. Avg.)

0

 Strengths

 Looks like the company does not have any notable strengths.

 Limitations

  • The company has shown a poor revenue growth of -7.06947978824379% for the Past 3 years.

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017
Net Sales 21.55 31.33 32.43 24.29 25.14
Total Expenditure 19.25 29.15 30.23 21.34 22.26
Operating Profit 2.3 2.17 2.2 2.96 2.88
Other Income 0.02 0.06 0.05 0.04 0.11
Interest 1.21 1.21 1.21 1.05 1.12
Depreciation 0.3 0.27 0.58 0.58 0.57
Exceptional Items 0 0 0 0 0
Profit Before Tax 0.81 0.75 0.46 1.38 1.3
Tax 0.07 0.06 0.09 0.31 0.33
Net Profit 0.74 0.69 0.37 1.07 0.98
Adjusted EPS (Rs.) 1.31 1.15 0.62 1.78 1.63

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2014 Mar 2015 Mar 2016 Mar 2017
Equity and Liabilities
Share Capital 1 1 1 6
Total Reserves 5.77 6.14 7.21 3.19
Borrowings 5.27 4.64 4.61 5.42
Other N/C liabilities 0.44 0.4 0.33 0.26
Current liabilities 10.36 11 10.01 11.36
Total Liabilities 22.84 23.17 23.16 26.23
Assets
Net Block 5.64 5.07 4.56 4.17
Capital WIP 0 0 0 0
Intangible WIP 0 0 0 0
Investments 0 0 0 0
Loans & Advances 0.13 0.13 0.07 0.07
Other N/C Assets 0 0 0 0
Current Assets 17.08 17.98 18.54 21.99
Total Assets 22.84 23.17 23.16 26.23
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2016 Mar 2017
Profit from operations 1.38 1.3
Adjustment 1.61 1.67
Changes in Assets & Liabilities -0.55 -2.47
Tax Paid -0.38 -0.41
Operating Cash Flow 2.05 0.08
Investing Cash Flow 0.06 -0.17
Financing Cash Flow -1.68 -0.27
Net Cash Flow 0.43 -0.36

Corporate Actions

Company News

 No Latest News available for this company.
Report us
Last Updated on:
Brief about Affine Formulations
X